Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;191(8):2057-2063.
doi: 10.1002/ajmg.a.63234. Epub 2023 May 5.

A homozygous Gly470Ala variant in PEX6 causes severe Zellweger spectrum disorder

Carolina I Galarreta  1 , Karen Wong  2 , Jason Carmichael  1 , Jeremy Woods  1 , Christina G Tise  3 , Annie D Niehaus  3 , Alison J Schildt  3 , Courtney P Verscaj  3 , Kristina P Cusmano-Ozog  4
Affiliations

A homozygous Gly470Ala variant in PEX6 causes severe Zellweger spectrum disorder

Carolina I Galarreta et al. Am J Med Genet A. 2023 Aug.

Abstract

Zellweger spectrum disorder (ZSD) is a group of autosomal recessive disorders caused by biallelic pathogenic variants in any one of the 13 PEX genes essential for peroxisomal biogenesis. We report a cohort of nine infants who presented at birth with severe neonatal features suggestive of ZSD and found to be homozygous for a variant in PEX6 (NM_000287.4:c.1409G > C[p.Gly470Ala]). All were of Mixtec ancestry and identified by the California Newborn Screening (NBS) Program to have elevated C26:0-lysophosphatidylcholine but no reportable variants in ABCD1. The clinical and biochemical features of this cohort are described within. Gly470Ala may represent a founder variant in the Mixtec population of Central California. ZSD should be considered in patients who present at birth with severe hypotonia and enlarged fontanelles, especially in the setting of an abnormal NBS, Mixtec ancestry, or family history of infant death. There is a need to further characterize the natural history of ZSD, the Gly470Ala variant, and expand upon possible genotype-phenotype correlations.

Keywords: Mixtec; PEX6; Zellweger spectrum disorder; founder effect.

PubMed Disclaimer

References

REFERENCES

    1. Armangue, T., Orsini, J. J., Takanohashi, A., Gavazzi, F., Conant, A., Ulrick, N., Morrissey, M. A., Nahhas, N., Helman, G., Gordish-Dressman, H., Orcesi, S., Tonduti, D., Stutterd, C., van Haren, K., Toro, C., Iglesias, A. D., van der Knaap, M. S., Goldbach Mansky, R., Moser, A. B., … Vanderver, A. (2017). Neonatal detection of Aicardi Goutières syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots. Molecular Genetics and Metabolism, 122(3), 134-139. https://doi.org/10.1016/j.ymgme.2017.07.006
    1. Bose, M., Yergeau, C., D'Souza, Y., Cuthbertson, D. D., Lopez, M. J., Smolen, A. K., & Braverman, N. E. (2022, Jun 10). Characterization of severity in Zellweger spectrum disorder by clinical findings: A scoping review, meta-analysis and medical chart review. Cells, 11(12), 1891. https://doi.org/10.3390/cells11121891
    1. Braverman, N. E., D'Agostino, M. D., & Maclean, G. E. (2013). Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives. Developmental Disabilities Research Reviews, 17(3), 187-196. https://doi.org/10.1002/ddrr.1113
    1. ClinVar. (n.d.). VCV000573090.9. https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000573090.9
    1. de Graaf, I. M., Pajkrt, E., Keessen, M., Leschot, N. J., & Bilardo, C. M. (1999). Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome. Ultrasound in Obstetrics & Gynecology, 13(4), 268-270. https://doi.org/10.1046/j.1469-0705.1999.13040268.x

MeSH terms

Substances

LinkOut - more resources